JOLENE CABRAL: Open Payments
NPI 1659988517 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 25 payments from 13 companies in 2025. Trend: 2023 $1,062 · 2024 $282 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $78 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Medtronic, Inc. | 1 | $25 |
| Koya Medical, Inc. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
Products named: LifeVest, LEQVIO, WAINUA, FUROSCIX, CAMZYOS, UPTRAVI, SELECTSECURE, KOYA MEDICAL.
Industry payments across MO — which companies pay providers there.
